Crossject is revolutionizing needle free injection

Paragraphes
Colonne 1

Crossject is revolutionizing the administration of well-established treatments with its needle-free auto-injector ZENEO®. The prefilled, single-use device propels the medicine through the skin in less than a tenth of a second. Crossject currently has eight solutions in advanced stages of development, seven of which are for emergency situations.  

Zeneo illustration

 

Our news

Image de l'actualité

Crossject will be attending J.P. Morgan Healthcare conference

Résumé de l'actualité

 January 13-16 2020, Crossject will be in San Francisco around the J.P. Morgan Healthcare Conference, to meet with American pharmaceutical companies.

Image de l'actualité

Cooperative agreement signed between Crossject and the US Department of Defense

Résumé de l'actualité

Crossject and the US Department of Defense have signed a cooperative research and development agreement for Zeneo® Midazolam